To investigate the potential predictors of response to regorafenib, in chemorefractory metastatic colorectal cancer (mCRC) patients with long-term efficacy from regorafenib treatment.
Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment
Martinelli, Erika;Sforza, Vincenzo;Cardone, Claudia;Martini, Giulia;Napolitano, Stefania;Reginelli, Alfonso;Morgillo, Floriana;Ciardiello, Fortunato;Troiani, Teresa;De Vita, Fernando
2017
Abstract
To investigate the potential predictors of response to regorafenib, in chemorefractory metastatic colorectal cancer (mCRC) patients with long-term efficacy from regorafenib treatment.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
regorafenib.pdf
accesso aperto
Tipologia:
Documento in Post-print
Licenza:
Dominio pubblico
Dimensione
728.87 kB
Formato
Adobe PDF
|
728.87 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
